Search results
2 Dividend Stocks Billionaires Are Buying: Should You?
Motley Fool via Yahoo Finance· 15 hours agoThe result is that Pfizer is quickly developing newer products that will eventually replace not just...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 16 hours agoLast year, sales tumbled 42% to nearly $58.5 billion. Top sellers included Comirnaty and Paxlovid,...
To Your Good Health: Purpura spots appear as skin begins to get thinner
The Marshall News Messenger· 2 days agoIn 2022, I had the WATCHMAN procedure. Prior to the WATCHMAN implant, I took Eliquis to help prevent...
2 No-Brainer Dividend Stocks You Can Buy With $100 in June
Motley Fool via Yahoo Finance· 5 days agoBoth offer above-average yields now, and they're well positioned to grow their dividend payouts....
Thinking Of Buying Pfizer For Its 5.8% Dividend Yield? Consider This Alternative Option Instead
Benzinga via Yahoo Finance· 14 hours agoPfizer Inc. (NYSE:PFE) has long been a favorite among income investors, thanks to its generous...
Why Things Could Get Worse for Pfizer Stock Before They Get Better
Motley Fool via Yahoo Finance· 3 days agoHowever, that will be partly offset by losses in revenue totaling between $16 billion and $18...
Millions of Americans need drugs like Ozempic. Will it bankrupt the health care system?
The Columbian· 6 days agoAn April 24 letter from Vermont Sen. Bernie Sanders to the CEO of Novo Nordisk began with heartfelt...
Here’s Why Jim Cramer Says You Should Not Buy Bristol-Myers Squibb Co (NYSE:BMY)
Insider Monkey via Yahoo Finance· 3 days agoWe recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Zacks via Yahoo Finance· 3 days agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
In February, Medicare began negotiating behind closed doors for lower drug prices
NPR· 4 days agoThe Inflation Reduction Act says Medicare can negotiate prices for 10 drugs that meet certain criteria. In this case, it's blockbuster blood thinners, like Eliquis and Xarelto ...